IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Dopamine and the Gut Microbiota: Interactions Within the Microbiota–Gut–Brain Axis and Therapeutic Perspectives
- Barbu A.C. , et al.
2. Lactiplantibacillus plantarum as a Psychobiotic Strategy Targeting Parkinson’s Disease: A Review and Mechanistic Insights
- Chen W.L. , et al.
3. Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease
- Poluektova E.U. , et al.
4. Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson’s disease
- Ramadan M.E. , et al.
5. Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases
- Olajide T.S. , et al.
6. The effect of diet on Parkinson's disease progression, symptoms and severity: A review of randomised controlled trials
- Prasad A. , et al.
7. Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from in vivo to Clinical Trial
- Kim J.H. , et al.
8. Comparative efficacy of non-pharmacological interventions for Parkinson’s disease with constipation: a systematic review and network meta-analysis
- Zhang P. , et al.
9. Efficacy of gut microbiota-targeted therapies in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
- Gu X. , et al.
10. The Role of the Gastrointestinal Microbiota in Parkinson’s Disease
- Gabrielli M. , et al.
11. Therapeutic role of probiotics in motor and non-motor symptoms of Parkinson’s disease
- Páez-García S. , et al.
13. Microbiome-based therapeutics for Parkinson's disease
- Hamilton A.M. , et al.
14. The effect of crocin on movement disorders and oxidative DNA damage in Parkinson's disease: Insights from a randomized controlled trial
- Mohammad Soleymani S. , et al.
15. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review
- Mincic A.M. , et al.